Taysha Gene Therapies
$4.31
55
-$0.16-3.58% Wednesday 20:00
Statistics
Day High
4.61
Day Low
4.3
52W High
6.02
52W Low
1.05
Volume
1,641,047
Avg. Volume
2,757,824
Mkt Cap
1.18B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
20MayExpected
Expected EPS
-0.097
Actual EPS
N/A
Financials
-1,071.62%Profit Margin
Unprofitable16.67MRevenue
-178.6MNet Income
Analyst Ratings
$10.80Average Price Target
The highest estimate is 13.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy 80%
Hold 20%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow TSHA. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Sarepta Therapeutics
SRPT
Mkt Cap2.51B
PTC Therapeutics
PTCT
Mkt Cap5.4B
Solid Biosciences
SLDB
Mkt Cap419.71M
Voyager Therapeutics
VYGR
Mkt Cap259.04M
Regenxbio
RGNX
Mkt Cap645.07M
About
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN1 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 foe the treatment of for SLC13A5 Deficiency; and TSHA-101 for the treatment of GM2 gangliosidosis. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center to develop and commercialize transformative gene therapy treatments. The company was incorporated in 2019 and is based in Dallas, Texas.
Show more...
CEO
Mr. Sean P. Nolan
Employees
73
Country
US
ISIN
US8776191061
Listings
0 Comments
Share your thoughts
FAQ
What is Taysha Gene Therapies stock price today?▼
The current price of TSHA is $4.31 USD — it has decreased by -3.58% in the past 24 hours. Watch Taysha Gene Therapies stock price performance more closely on the chart.
What is Taysha Gene Therapies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Taysha Gene Therapies stocks are traded under the ticker TSHA.
Is Taysha Gene Therapies stock price growing?▼
TSHA stock has fallen by -0.23% compared to the previous week, the month change is a -4.86% fall, over the last year Taysha Gene Therapies has showed a +226.52% increase.
What is Taysha Gene Therapies market cap?▼
Today Taysha Gene Therapies has the market capitalization of 1.18B
When is the next Taysha Gene Therapies earnings date?▼
Taysha Gene Therapies is going to release the next earnings report on May 20, 2026.
What were Taysha Gene Therapies earnings last quarter?▼
TSHA earnings for the last quarter are -0.08 USD per share, whereas the estimation was -0.1 USD resulting in a +16.32% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Taysha Gene Therapies revenue for the last year?▼
Taysha Gene Therapies revenue for the last year amounts to 16.67M USD.
What is Taysha Gene Therapies net income for the last year?▼
TSHA net income for the last year is -178.6M USD.
How many employees does Taysha Gene Therapies have?▼
As of April 02, 2026, the company has 73 employees.
In which sector is Taysha Gene Therapies located?▼
Taysha Gene Therapies operates in the Health Care sector.
When did Taysha Gene Therapies complete a stock split?▼
Taysha Gene Therapies has not had any recent stock splits.
Where is Taysha Gene Therapies headquartered?▼
Taysha Gene Therapies is headquartered in Dallas, US.